Navigation Links
An efficient approach to monitor gastrointestinal microflora changes
Date:5/22/2009

Pi-deficiency in traditional Chinese medicine (TCM) is one of the most common digestive diseases and usually the equilibrium of gastrointestinal microflora are broken, which plays many important roles in the growth, development and performance of the host. Therefore, more clinical interests are arising in monitoring changes of intestinal microflora in intestinal disease and the consequent treatment, especially in TCM therapies. It has been found that some Chinese materia medica have curative effects on regulating the equilibrium of intestinal microflora and therefore promote the recovery of 'Pi'. However, ways of monitoring the intestinal flora are quite limited, not only because of the complexity of its constitution, but also the difficulty of culturing for most gastrointestinal bacteria in vitro.

A research article to be published on May 14, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Li from School of Pharmacy of Shanghai Jiao Tong University, China, used enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR), which is a PCR-based molecular method, and utilizes oligonuleotides targeting short repetitive sequences ERIC which are dispersed throughout various bacterial genomes, to study changes of intestinal microflora under Pi-deficiency state and evaluate therapeutic effects of Chinese materia medica.

ERIC-PCR have implications in monitoring the effects of various known factors on the complex intestinal microflora community. The article introduced it to examine the changes of intestinal mircoflora of Pi-deficiency disorder with two animal models. They further evaluate the efficacy of four Chinese materia medicas as well as a probiotic and another disease therapy recipe in Pi-deficient rats, and determine if it could be utilized as an initial screening of changes of the composition of bacterial communities.

A molecular marker was identified for Pi-deficiency in rats. The pharmacodynamic evaluating system, including identified molecular markers (net integral area and abundance of DNA band), Shannon's index for diversity of intestinal microflora, and Sorenson's pairwise similarity coefficient, was established. With application of this evaluating system, four major clinical recipes used for Pi-deficiency therapy in TCM were demonstrated to produce more pronounced recovery activities on the Pi-deficient rats, especially the middle dose (equivalence to the clinical dose), while the higher doses of these recipes did not show a better therapeutic effect even showed some perturbation deterioration of intestinal microflora.

Both the fingerprint analysis and the identified marker were demonstrated to distinguish the Pi-deficiency. The identified molecular marker may have application in the screening of active compounds in relative Chinese materia medicas and pharmacodynamic study in Pi-deficiency.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. New Smart Technology Makes Patient Data Collection Easier, More Efficient
2. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
3. Medical Affairs: Building Efficient Medical Affairs Functions That Drive Product Marketing Success
4. Building efficient, effective, locally sensitive solutions for dementia care
5. Historic Agreement Reached to More Expertly and Efficiently Expand Proton Therapy Worldwide
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. More Efficient, Effective and Personal Patient Care at New McCune-Brooks Hospital Made Possible by Siemens HiPath(R) Wireless
8. Thomson Healthcare Study Finds That Hospitals Delivering High-Quality Heart Care Are Efficient and Cost Effective, Too
9. Using Efficient Communication to Boost Pharma Sales Force Productivity
10. Combined Boards Provide Better Care to More Clients More Efficiently
11. Antidepressants that are more efficient and faster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... A Palm Beach doctor plans to run the 2017 London ... provides free surgery to poor children suffering from cleft lip and cleft palate. , ... to support the efforts of the American Heart Association and the Leukemia and Lymphoma ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an ... implants dentistry. His modern dental practice has two convenient office locations in Alexandria and ... Rated Dentist for the Alexandria area. This award confirms the fact that ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... gum disease to enamel erosion, and those dental problems can increase the risk ... Health, many pregnant women are failing to get the dental care they need. ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... of difference. Eden Activewear is a stand-out company for several differences from other ... and only manufacture on demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html ...
(Date:1/17/2017)... St. Petersburg, Florida (PRWEB) , ... January 17, 2017 , ... ... and the Producers of AsSeenOnTV.pro will be featuring DRTV campaigns regarding the topic of ... year to become a better version of themselves. What better way to commit to ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017 Paragon Bioservices received a ... development services for a variety of National ... medical product development activities. The IDIQ mechanism will ... for task order awards up to $159 million. ... manufacturing and process development of biopharmaceuticals, is one ...
(Date:1/17/2017)... Management to Discuss Acquisition of Oncology ... On Track For An NDA Submission to ...   ... KTOV ; TASE: KTOV), an innovative biopharmaceutical company, announced that it will ... Eastern Time to discuss the recent acquisition of a majority stake in TyrNovo, ...
(Date:1/17/2017)... DUBLIN , Jan. 17, 2017  Jazz Pharmaceuticals ... first patient has been enrolled in a Phase 3 ... versus best supportive care (BSC) in the prevention of ... undergoing hematopoietic stem cell transplant (HSCT) who are at ... VOD.  The defibrotide clinical trial will be conducted across ...
Breaking Medicine Technology: